Search details
1.
Rare germline mutations in African American men diagnosed with early-onset prostate cancer.
Prostate
; 78(5): 321-326, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29356034
2.
Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.
Hum Genet
; 135(8): 923-38, 2016 08.
Article
in English
| MEDLINE | ID: mdl-27262462
3.
Germline mutations in HOXB13 and prostate-cancer risk.
N Engl J Med
; 366(2): 141-9, 2012 Jan 12.
Article
in English
| MEDLINE | ID: mdl-22236224
4.
Identification of a novel germline SPOP mutation in a family with hereditary prostate cancer.
Prostate
; 74(9): 983-90, 2014 Jun.
Article
in English
| MEDLINE | ID: mdl-24796539
5.
Mutational landscape of candidate genes in familial prostate cancer.
Prostate
; 74(14): 1371-8, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-25111073
6.
Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease.
Hum Genet
; 133(3): 347-56, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-24162621
7.
Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy.
BJU Int
; 113(5): 830-5, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24148311
8.
HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).
Hum Genet
; 132(1): 5-14, 2013 Jan.
Article
in English
| MEDLINE | ID: mdl-23064873
9.
Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy.
J Urol
; 189(3): 849-53, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-23036981
10.
Early onset prostate cancer has a significant genetic component.
Prostate
; 72(2): 147-56, 2012 Feb 01.
Article
in English
| MEDLINE | ID: mdl-21538423
11.
Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG).
Hum Genet
; 131(7): 1095-103, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22198737
12.
Genetic variation in glutathione S-transferase omega-1, arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a case-control study.
Environ Health
; 11: 43, 2012 Jun 29.
Article
in English
| MEDLINE | ID: mdl-22747749
13.
Evidence for an association between prostate cancer and chromosome 8q24 and 10q11 genetic variants in African American men: the Flint Men's Health Study.
Prostate
; 71(3): 225-31, 2011 Feb 15.
Article
in English
| MEDLINE | ID: mdl-20717903
14.
Sequence variation in the mitochondrial gene cytochrome c oxidase subunit I and prostate cancer in African American men.
Prostate
; 69(9): 956-60, 2009 Jun 15.
Article
in English
| MEDLINE | ID: mdl-19267350
15.
Genome-wide linkage scan for prostate cancer susceptibility from the University of Michigan Prostate Cancer Genetics Project: suggestive evidence for linkage at 16q23.
Prostate
; 69(4): 385-91, 2009 Mar 01.
Article
in English
| MEDLINE | ID: mdl-19035517
16.
Chromosome 8q24 markers: risk of early-onset and familial prostate cancer.
Int J Cancer
; 122(12): 2876-9, 2008 Jun 15.
Article
in English
| MEDLINE | ID: mdl-18360876
17.
Association between germline variation in the FHIT gene and prostate cancer in Caucasians and African Americans.
Cancer Epidemiol Biomarkers Prev
; 16(6): 1294-7, 2007 Jun.
Article
in English
| MEDLINE | ID: mdl-17548701
18.
Common variation in the BRCA1 gene and prostate cancer risk.
Cancer Epidemiol Biomarkers Prev
; 16(7): 1510-6, 2007 Jul.
Article
in English
| MEDLINE | ID: mdl-17585057
19.
Assessing the Cumulative Contribution of New and Established Common Genetic Risk Factors to Early-Onset Prostate Cancer.
Cancer Epidemiol Biomarkers Prev
; 25(5): 766-72, 2016 05.
Article
in English
| MEDLINE | ID: mdl-26671023
20.
Identifying susceptibility genes for prostate cancer--a family-based association study of polymorphisms in CYP17, CYP19, CYP11A1, and LH-beta.
Cancer Epidemiol Biomarkers Prev
; 14(8): 2035-9, 2005 Aug.
Article
in English
| MEDLINE | ID: mdl-16103457